To evaluate the Safety and efficacy of Unani formulations in the treatment of Premature ejaculation

Clinical observational validation of unani pharmacopoeial drugs Majoon-e-Aradkhurma, Safoof-e-mughalliz-e-Mani, Qurs-e- Iksaeer-e-Shifa in the cases of Premature ejaculation (Surat-e-Inzaal )

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/01/004267

Enrollment

300

Registered

2014-01-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N538- Other male sexual dysfunction Health Condition 2: null- Surat-e-Inzaal (Premature ejaculation )

Interventions

Intervention1: 1. Safoof Mugalliz-e-Mani 2.Majoon Aarad-e-Khurma 3.Tab Habb-e-Akseer-e-Shifa: 1.Safoof Mugalliz-e-Mani -7 gms TWICE A DAY orally 2.Majoon Aarad-e-Khurma - 10 gm TWICE A DAY orally 3.Ta

Eligibility

Inclusion criteria

Inclusion criteria: 1. Men with an IELT ( Intravaginal ejaculatory latency time) of less than 1 minute will be included in the study

Exclusion criteria

Exclusion criteria: 1 Patients with Erectile Dysfunction 2 Patients with diseases requiring long term treatment

Design outcomes

Primary

Measure	Time frame
Improvement in signs and symptomsTimepoint: 6 weeks	—

Secondary

Measure	Time frame
Hematological and biochemical assessments for safetyTimepoint: 6 weeks	—

Countries

India

Contacts

Public ContactDr Abdul Hannan

Central Council for Research in Unani Medicine (CCRUM

ccrum605@gmail.com011-28521981

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026